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Abstract 
Plants engineered with genes encoding for
the antigenic proteins of various microorgan-
isms have shown to correctly express the pro-
teins that elicit the production of antibodies in
mammalian hosts. In livestock, plant-based
vaccines could represent an innovative strate-
gy for oral vaccination, especially to prevent
infection by enteric pathogens. The aim of this
study was to evaluate tobacco plants as a seed-
specific expression system for the production
of the flgK flagellar hook-associated protein
from a wild type Salmonella typhimurium
strain, as a model of an edible vaccine. The
flgK gene is the principal component of bacte-
rial flagella and is recognised as virulence fac-
tor by the innate immune system. It was isolat-
ed from the Salmonella typhimurium strain by
PCR. The encoding sequence of flgK was trans-
ferred into a pBI binary vector, under control of
soybean basic 7S globulin promoter for the
seed-specific. Plant transformation was car-
ried out using recombinant EHA 105
Agrobacterium tumefaciens. A transgenic popu-
lation was obtained made up of independently
kanamycin-resistant transgenic plants, which
had a similar morphological appearance to the
wild-type plants. Molecular analyses of seeds
confirmed the integration of the gene and the
average expression level of flgK was estimated
to be about 0.6 mg per gram of seeds, corre-
sponding to 0.33% of the total amount of solu-
ble protein in tobacco seeds. This study
showed that the foreign flgK gene could be sta-
bly incorporated into the tobacco plant genome
by transcription through the nuclear apparatus
of the plant, and that these genes are inherited
by the next generation. 
Introduction
Plants are interesting expression systems
for the effective and financially viable produc-
tion of recombinant proteins for therapeutic
and medical purposes (Streatfield et al., 2001;
Daniell et al., 2009). Plant systems represent a
relatively inexpensive way for the expression
and large-scale production of proteins rather
than using industrial methods (fermentation
of bacteria, yeast, cultured animal or human
cell lines) and have the ability to carry out
post-translational modifications similar to nat-
urally-occurring systems (Streatfield, 2006).
Several studies have shown that plants that
have been engineered with genes encoding for
antigenic proteins of various microorganisms
correctly express the proteins that elicit the
production of antibodies in mammalian hosts
(Lamphear et al., 2002; Rossi et al., 2003a,
2003b; Pinotti et al., 2003). Plant-based vac-
cines offer different advantages (Salazar-
Gonzales et al., 2013). The risk of contamina-
tion from potential animal pathogens is min-
imised, as plants are not hosts for mammalian
infectious agents (Giddings et al., 2000).
Plant-based vaccines offer a convenient way of
storage: they do not need to be maintained in
a cold chain, as the plant parts expressing the
vaccine or plant extracts can be stored and
transported at room temperature. In addition,
if orally administered by feeding, production
costs can be reduced by almost 90%, thus
avoiding purification from plants, and elimi-
nating the syringes and needles in the delivery
of vaccines. In livestock, plant-based vaccines
could represent an innovative strategy for oral
vaccination, especially to prevent infection by
enteric pathogens. Furthermore, edible vac-
cines could be an efficient way to reduce
antibiotic treatments, in compliance with EC
Regulation 1831/2003. In fact, an effective oral
vaccination could increase the likelihood of a
local immune response at the site of infection,
thus avoiding systemic symptoms. 
Tobacco plays an important role in the
advancement of plant biotechnology. It has
been found to be extremely versatile for genet-
ic manipulation and tissue culture research
(Ganapathi et al., 2004). Several recombinant
proteins have been expressed in transgenic
tobacco as bioreactors for the production of
commercially important pharmaceutical mole-
cules (Shoji et al., 2012). Many immunogenic
proteins have been synthesised in tobacco and
several plant-based vaccine candidates have
demonstrated efficacy against a large number
of human and animal pathogens after oral
administration (Daniell et al., 2001). However,
antigenic proteins expressed in tobacco
require a very thorough purification process,
which represents the main cost involved in
recombinant protein production, because of
the presence of nicotine in leaves, which is
about 200 mg/kg. Previous studies have shown
that tobacco seeds, which have less than 2
µg/kg of nicotine, can be integrated into live-
stock feeding without affecting the palatability
(Rossi et al., 2007) or metabolic parameters. A
recent study showed that tobacco seed cake, a
by-product obtained after oil extraction, could
be used as a cost-effective protein source in
piglet nutrition (Rossi et al., 2013b). It is also
included in the EU feed material register
(number 00753-IT). Enteric diseases represent
a serious problem in the pig industry and are
responsible for significant economic losses
(Rossi et al., 2012). 
We focused on Salmonella typhimurium,
which is responsible for considerable econom-
ic losses in pigs and which represents a major
zoonotic pathogen (Foley and Lynne, 2008).
The transmission of Salmonella typhimurium
in swine occurs mainly through the faecal-oral
route, with invasion through the intestinal
wall and Peyer’s patches. Although invasion of
the intestinal epithelium is a required viru-
lence factor of all salmonellae, invasiveness
may be limited to certain times and host sites
during pathogenesis (Fedorka-Cray et al.,
1995). The most commonly studied virulence
factors are flagella, which play a pivotal role in
the motility and invasion of the mucosal sur-
face. Flagella of S. typhimurium have been
shown to stimulate both the innate and adap-
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tative immune system (Olsen et al., 2013).
Flagellins, component of bacterial flagella, are
recognised by the innate immune system in
mammals (Hayashi et al., 2001) and induce
systemic and mucosal immune responses after
intranasal immunisation (Strindelius et al.,
2004). Non-flagellated serotype Salmonella
typhimurium mutants have been shown to
cause less inflammation than their isogenic
parents after infection of bovine ligated ileal
loops (Macnab, 2003). In particular, flgK, a
hook-associated protein, appeared to be the
most immunoreactive protein (Kwang and
Littledike, 1995). In swine, salmonellosis is a
serious problem responsible for enterocolites
of a variable severity, followed by a carrier
state that can last up to 28 weeks (Rementeria
et al., 2009; Gebreyes and Altier, 2002). This
carrier status maintains the infection in the
farms involved, and is thus an important public
health risk (Boyen et al., 2009). According to
an EFSA report, the prevalence of Salmonella-
positive slaughter pigs was as high as 10.3%,
although this figure varied among member
states, including both primary infections and
surface contamination of carcasses. Of partic-
ular concern is the increasing number of infec-
tions with antimicrobial drug-resistant
Salmonella, including the recent emergence of
drug-resistant Salmonella enterica serotype
typhimurium (Helms et al., 2002). Novel meth-
ods are required to control salmonellosis in
livestock, and vaccination is an effective way to
prevent the disease. An efficient vaccination
strategy could also reduce antibiotic treat-
ments, as suggested by EC Regulation
1831/2003.
The aim of this study is to evaluate tobacco
plants as a seed-specific expression system for
the production of flgK gene – the principal
component in bacterial flagella and recognised
as a virulence factor by the innate immune
system – from a wild type Salmonella
typhimurium strain, as a model of an edible
vaccine.
Materials and methodsIsolation of flgK gene fromSalmonella typhimurium strain
The Salmonella typhimurium strain, isolated
from a piglet that had died from salmonellosis,
was grown in triptone soy broth (Oxoid,
Basingstoke, UK) at 37°C for 24 h. A 1 mL
aliquot of enrichment broth was centrifuged
(2500 x g for 10 min) and the pellet was resus-
pended in 474 µL of TE (10 mM Tris-HCl pH 8, 1
mM Na2EDTA), 25 µL 10% SDS and 1.25 µL pro-
teinase K (20 mg/mL). After incubation at 55ºC
for 30 min, 500 µL of phenol-chloroform pH 8
(1:1) was added, mixed vigorously, and the sam-
ples were centrifuged (10,000 x g, 10 min). The
aqueous phase was transferred to a fresh micro-
tube, and the DNA was precipitated with 3 M
sodium acetate and ice-cold isopropanol for 30
min. Samples were centrifuged (16,000 x g for
10 min) and the pellet was washed with 90%
ethanol. The final pellet was resuspended in 50
mL of TE, and was then stored at 4ºC until PCR
was performed. The primer pair was designed
on the flgK gene sequence (Genebank,
Accession Number: X51738), codifying for the
flgK flagellar protein made up of 552 amino
acids, in order to detect the entire gene from
start to stop codon (81 to 1742). Oligonucleotide
primers (5’ggatccatgtccagcttgattaatcacgcc and
3’ aaactacgcaataacttataagcgattctcgag) included
unique cloning sites for specific endonucleases
(BamHI - 5’, SacI - 3’) to facilitate direct sub-
cloning of the fragments in the plant transfor-
mation vector. A polymerase chain reaction was
performed in order to obtain one DNA fragment
of 1662 pb corresponding to the flgK gene. An
aliquot of 5 µL of bacterial genomic DNA was
used as the template DNA in the PCR. Negative
controls were represented by the PCR mix
(without DNA template) and genomic DNA
extracted from the BL21 E. coli strain. The PCR
mixture consisted of 5 µL of amplification
buffer (Promega, Fitchburg, WI, USA), 1.5 mM
MgCl2, 200 mM (each) of the four deoxyribonu-
cleoside triphosphates, 1 mM (each) of primer
pairs, 1.25 U of Taq polymerase (Promega), and
distilled H2O, which was added to make a total
volume of 50 µL. The parameters for the ampli-
fication cycles were as follows: 25 cycles of 1
min of denaturation at 94°C, 1’ 20’’ of annealing
at 55°C, and 1’ 30’’ of extension at 72°C.
Aliquots of PCR products were electrophoresed
in a 0.8% agarose gel. After staining with ethid-
ium bromide, the amplified DNA fragments in
the gel were visualised and photographed under
UV illumination. The amplified flgK gene, puri-
fied from agarose gel (Geneclean; Q-BioGene,
Irvine, CA, USA), were inserted by ligation into
a high copy number plasmid vector (pGEM-T
Easy; Promega) in order to obtain a pGEM-T
Easy-flgK chimeric construct. pGEM-T Easy-flgK
was cloned into (TetR) XL1B E. coli strain by
electroporation for preliminary clone selection.
Restriction analyses were carried out on plas-
midic DNA extracted from XL1b E. coli strains
growth on LB medium containing tetracycline
and ampicillin as markers of transformation.
Restriction analyses were carried out with
EcoRI, BamHI and SacI in order to evaluate the
correct insertion of the flgK gene.
Expression of recombinant flgKthrough pET system 
E. coli BL21 competent cells (Novagen,
Madison, WI, USA) were transformed with the
expression plasmid pET-28a containing the
flgK gene and selected on LB-Kan plates
(kanamycin 30 µg/mL). A single recombinant
colony was inoculated with 5 mL of the LB
medium containing kanamycin (37°C, o/n). A
total of 1 mL of the pre-inoculum was added to
100 mL of the LB medium in a 1 L flask, and
incubated with shaking (175 rpm at 37°C)
until the OD600 reached 0.6. Isopropyl- beta-D-
thiogalactoside (IPTG) was added to the cul-
ture to a final concentration of 0.1 mM and the
incubation was continued for another 2 h. The
culture was incubated for an additional 3 h and
then harvested by centrifugation. The soluble
protein fraction and inclusion body proteins
were eluted separately in columns with a spe-
cific resin. The proteins were resolved by 10%
polyacrylamide gel electrophoresis (PAGE).
Detection was performed by Coomassie blue
staining. The purified flgK protein was concen-
trated in a 4 M urea elution buffer with a cen-
trifugal filter (10 kD molecular weight cut-off)
(Centricon; Millipore, Billerica, MA, USA). The
flgK was evaluated on a sodium dodecyl sul-
phate (SDS)-PAGE. The purified proteins were
stored at -80°C. The protein concentration of
the crude samples was determined by the
Bradford’s (Bio-Rad) method with bovine
serum albumin as a standard. A total of 250 µg
of purified flgK in 1 mL of sterile PBS was
emulsified with an equal volume of complete
Freund’s adjuvant and injected into a New
Zealand white rabbit subcutaneously on the
dorsal site. Subsequent immunisations were
given with incomplete Freund’s adjuvant at 20-
day intervals. After three immunisations, the
rabbit was bled, and the titre of antibodies in
the serum samples was evaluated and stored at
-20°C.Construction of the expression cas-sette
The flgK gene obtained by SacI/BamHI
digestion of pGEM-T Easy-flgK, after purifica-
tion from the agarose gel, was separately sub-
cloned in a pBIpGLOB vector (Patent
WO0004146) using ligation. The soybean basic
7S globulin promoter (GLOB) (DDBJ
Accession number: AX006477) was used for
the seed-specific expression of antigenic pro-
teins according to Reggi et al. (2005). The
pBIpGLOB vector was linearised by the BamHI-
SacI restriction enzyme digestion, obtaining,
after elimination of the GUS gene, a plasmid of
13938 pb. A total of 100 ng of the pBIpGLOB
vector (linearised by SacI-BamHI digestion),
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17 ng of the flgK SacI-BamHI  fragment, 1 L of
the ligase buffer 10 X and 1 U of T4 DNA ligase
(Promega) were incubated with nuclease-free
water (to final volume of 10 μL) at 4°C
overnight. In the expression cassette, the flgK
gene was inserted under the control of GLOB
promoter in order to induce the seed specific
expression (Appendix). The ligation reaction
was used to transform competent cells of the
XL1B E. coli strain by electroporation, main-
tained in a selective medium containing
kanamycin for clone selection. The chimeric
constructs pBIpGLOB-flgK was evaluated by
restriction analyses.Tobacco transformation and regen-eration
Agrobacterium tumefaciens EHA 105 compe-
tent cells were transformed with the chimeric
construct pBIpGLOB-flgK by electroporation.
Recombinant Agrobacterium strains were
screened on a selective medium and using a
PCR assays in order to evaluate the presence
of the flgK gene. For the infection of 100 tobac-
co leaf disks with recombinant Agrobacterium,
we used an overnight culture of bacterium,
whose optical density at 600 nm (OD600) was
about 0.6. We then put a tobacco leaf disk
(Nicotiana tabacum L., cv. Xanthi) on
Murashige Skog 10 (MS10) medium for two
weeks to allow callus shaping. The kanamycin
that was incorporated into the medium
enabled the transformed callus tissue to be
selected, as previously described by Rossi et al.
(2003a). Regenerated shoots were separated
from the callus and cultured on a rooting medi-
um MS with 30 mg/L of kanamycin. The regen-
erated plants were finally transferred to the
soil and grown to maturity in a greenhouse in
homogeneous environmental conditions. 
The plants were analysed for the presence of
foreign DNA using internal primers of the flgK
sequence by PCR, using, for each sample 80 ng
of genomic DNA extracted from young leaves
of the regenerated plants as a template,
according to Doyle and Doyle (1987). The
mRNA was evaluated by northern blot analysis
on the immature seeds (12 days after pollina-
tion) of all PCR-positive plants. Northern blot
analysis was carried out using DIG-labelled
RNA probes hybridised with total RNA extract-
ed with one volume of 50 mM Tris buffer pH 7.5
containing 150 mM NaCl, 5 mM ethylendi-
aminetetracetic acid (EDTA), 1% sodiumdo-
decilsolphate (SDS), 150 mM B-mercap-
toethanol and one volume of phenol:chloro-
form (1:1). Electrophoresis, blotting and
hybridisation were performed as described
previously, and the specific RNA detection was
performed using CDP-star (Boehringer,
Mannheim, Germany) according to the manu-
facturer’s instructions. The total proteins were
extracted from all the mature transformed
tobacco lines by homogenisation with liquid N2
with the solubilisation buffer (50 mM Tris, pH
8, 5 mM EDTA, 200 mM NaCl, 0.1% Tween 20)
in a mortar. Protein content was estimated by
a Bradford assay (Bio-Rad, Hercules, CA, USA)
using bovine serum albumin as the standard.
The expression of flgK in the total protein sam-
ple was evaluated by western blotting with spe-
cific polyclonal antibodies obtained from New
Zealand rabbits, after immunisation with flgK
expressed through pET-system (Novagen) in a
BL21 E. coli strain. Samples (80 µg total pro-
tein) were loaded in a 10% polyacrylamide gel
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Figure 1. Electrophoresis of PCR products for the detection of flgK gene on agarose gel
(0.8%); flgK gene is represented by DNA fragments of 1662 pb. Lane M, marker; lane 1,
negative control (PCR mix); lanes 2 and 3, positive samples; lane 4, negative control
(genomic DNA from BL21 E. coli strain).
Figure 2. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis for the evaluation
of the expression rate of the flgK protein (molecular weight of 59 kD) through pET-28 a
system. Lane 1, protein extract without IPTG induction; lane 2, proteins isolated from
inclusion bodies after IPTG induction; lane 3, soluble protein fraction without IPTG
induction; lane 4, soluble protein fraction with IPTG induction; m, marker. 
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together with the Precision Standards (Bio-
Rad) and a positive control represented by 200
ng of flgK protein obtained through pET-sys-
tem (Novagen) in BL21 E. coli strain. The pro-
teins were transferred to an Immobilon-PSQ
membrane (Millipore) with the Trans-Blot SD
apparatus (Bio-Rad); the filters were incubat-
ed overnight with rabbit polyclonal anti-flgK
serum (1:5000). After incubation for 1 h with
HRP-conjugated secondary antibody
(1:10,000), chemiluminescence was developed
using the SuperSignal West Pico Trial Kit
(Thermo Fisher Scientific, Rockford, IL, USA).
The best positive producing lines were select-
ed and self-pollinated. The R1, and then, R2
generations were propagated in a greenhouse.
R1 and R2 tobacco leaf samples were collected
in order to evaluate by PCR, using the same
experimental conditions previously described,
the stable integration of flgK into tobacco
genome.  
Results and discussion 
Transgenic plants offer an attractive alter-
native to microorganisms and animals for the
production of novel vaccine antigens. Edible
vaccines represent an interesting challenge
for the control of various human and animal
diseases. The aim of our experimental design
was to engineer tobacco plants for the seed-
specific expression of the flgK protein, which
would induce, upon oral administration, the
production of specific mucosal antibodies
against Salmonella typhimurium. The loss or
inactivation of flgK by specific antibodies leads
to a reduction in the pathogenicity of
Salmonella typhimurium. The flgK flagellin, a
hook-filament junction protein of Salmonella
typhimurium, was chosen as an antigen. In
fact, flgK is recognised as an important viru-
lence factor by an innate immune system and
contributes to intestinal inflammation. The
development of a mucosal vaccination system
is an innovative way to produce specific anti-
bodies in the mucosal, where the major
pathogens gain access to the body.
The first step was to isolate the flgK gene
from Salmonella typhimurium wild type. The
flgK flagellin, electrophoresis of PCR products
for the detection of the flgK gene on agarose
gel identified flgK genes as bands with a
length of 1662 (Figure 1). Negative controls
did not show bands. Since the inserted prod-
ucts showed the expected size in the agarose
gel, they were recovered from the gel, diafil-
trated against water and ligated into plasmid T-
vectors for restriction analyses. The flgK gene
was identified by BamHI/SacI restriction
analysis of positive clones, grown on a selec-
tive medium. The results confirmed the correct
insertion of flgK gene and the match of the
obtained gene sequence with the GenBank.
The pET expression system was used for the
cloning and expression of recombinant pro-
teins in E. coli. The flgK gene was cloned in
pET-28a plasmid under the control of strong
bacteriophage T7 transcription and expres-
sion. Our results showed that T7 RNA poly-
merase was effectively induced by IPTG and
flgK proteins were significantly detected in the
total E. coli protein. The flgK proteins were
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Figure 3. Phases of plant transformation. a, tobacco leaf disks, infected with
Agrobacterium tumefaciens, in germinating medium; b, callus formation on selective
medium containing kanamycin; c, regenerated shoots separated from callus; d, regener-
ated tobacco plants on selective medium for shoots developing; e, transformed tobacco
plants in soil; f, transgenic plant in flowering stage in the greenhouse.
Figure 4. Western blot of flgK. Lanes 1 and 2, positive samples; WT, negative samples rep-
resented by total soluble protein from wild type seeds; M, positive control represented by
200 ng of flgK expressed through pET-system in BL21 E. coli strain. Signal analysis, by
comparison with the marker, estimated 600 ng of protein in lane 1 and about 100 ng of
protein in lane 2.
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accumulated as insoluble aggregates defining
inclusion bodies (Figure 2). This meant that
the recombinant proteins were easily isolated
by centrifugation and yielded highly concen-
trated and relatively pure protein. In addition,
it is known that the formation of inclusion bod-
ies protects the protein from citoplasmatic pro-
teolytic attack. Signals corresponding to flgK
proteins were not detected in soluble protein
fractions, no differences were observed
between soluble proteins with IPTG induction
and without IPTG induction. A total of 2 mg of
purified flgk, concentrated through a
Centricon ultrafiltration set-up, were stored at
-20°C. Obtained flgK proteins, expressed by
pET expression system, were used as positive
controls and for the production of specific rab-
bit serum used in subsequent western blot
assays.
The third step involved the evaluation of
tobacco plants as a seed-specific expression
system of the isolated flgK gene. Thus, the flgK
gene was subcloned in the binary vector
pBIpGLOB instead of the gusA gene. After the
engineered vector had been mobilised to A.
tumefaciens EHA 105, tobacco transformation
was carried out following standard procedures
(Rossi et al., 2013a). Several shoots, surviving
levels of kanamycin, antibiotic selective
agents, were obtained (Figure 3). A transgenic
population consisted of 15 independent
kanamycin-resistant transgenic plants, which
had a similar morphological appearance to the
wild-type plants. About 80% of the lines of
transformed tobacco plants, screened for the
presence of genes by PCR on DNA from young
leaves, harboured transgenes. Samples con-
taining transgenes were identified by the pres-
ence of an amplified product of 1.6 Kb, repre-
senting the gene encoding flgK fimbriae.
Molecular analyses confirmed the integration
and the expression of the flgK gene. Northern
blot analyses were performed on tobacco seeds
in order to select transcription positive trans-
formants as well as to verify that the mRNA
had been processed correctly and to estimate
RNA abundance, depending on the position
effects of the integrated transgene. Northern
blot analyses showed signals corresponding to
flgK mRNA in seven plants, corresponding to
60% of the PCR positive flgK plants. Different
lines were compared for transgene transcrip-
tion and lines with the strongest signals were
selected for subsequent plant generations.
Western blot analysis, carried out on plants
positive for flgK mRNA, detected flgK signals in
all samples. By comparison with a positive con-
trol (200 ng of flgK protein expressed by pET
system in BL21 E. coli strain), the best produc-
ing lines (Figure 4) showed an amount of flgK
protein of 600 ng per 80 µg of total soluble pro-
tein (0.75%), corresponding to 1.5 mg per
gram of seeds (considering that the crude pro-
teins in tobacco seeds are about 20%). The
lowest observed level of expression was
amounted to 0.125% of total soluble proteins.
The different level of expression of regenerat-
ed plants is caused by Agrobacterium-mediated
transformation at random positions in the
tobacco genome. Nevertheless, the average
amount of flgK was estimated to be about 0.6
mg per gram of seeds, corresponding to 0.33%
of the total soluble protein in tobacco seeds.
The obtained number of antigens (per gram of
seeds), according to other authors, is suffi-
cient for subsequent trials focusing on the in
vivo evaluation of the oral administration of
tobacco seeds transformed for flgK seed-
expression (Lamphear et al., 2002; Streatfield
et al., 2001). No cross-reacting proteins were
identified in any of the wild-type seed extracts.
No traces of degradation products were appar-
ent in any of the transformed samples. The
best lines of tobacco-regenerated plants were
selected, propagated in vitro and then grown in
a greenhouse. Obtained data showed the
inheritance of transgenes in the R0, R1 and R2
generations (Figure 5) and the stable integra-
tion of flgK gene into tobacco genome. The
production of antigens in seeds has the advan-
tage of a long storage period and a natural
encapsulation in the tissues of the expression
host. This encapsulation offers the potential
for the antigen to be protected against rapid
and complete degradation and to be gradually
released as host tissues are digested (Rossi et
al., 2011). As previously discussed, the inclu-
sion of tobacco seeds in the piglet diet was able
to cover the nutritional requirements without
affecting growth, feed efficiency and metabolic
parameters and can thus be used as a protein
source (Rossi et al., 2013b). In order to reduce
the volume of vaccine seeds, tobacco seed cake
obtained through cold pressing can be used,
which would be an effective way to obtain a
higher concentration of heterologous proteins.
Conclusions
This study has shown that the foreign flgK
gene, derived from a wild type Salmonella
typhimurium strain, can be stably incorporated
into the tobacco plant genome by transcription
through the nuclear apparatus of the plant for
specific expression in the seeds, and that
these genes are inherited by the next genera-
tion. Tobacco seeds could then be used as an
effective system for flgK flagellin expression.
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APPENDIX
Restriction map of pBIpGLOB binary vector. The flgK gene was inserted, after BamHI/SacI digestion of pBIpGLOB plasmid, under
control of GLOB promoter and NOS terminator. The expression cassette included also NPT II gene, as marker, responsible for
kanamycin resistance.
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